🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/10/2003 | 49,56 | 52,85 | 49,15 | 51,58 | +3,69% | 7,48% | 282.449 |
| 30/10/2003 | 51,05 | 51,39 | 49,03 | 49,74 | -1,41% | 4,62% | 133.476 |
| 29/10/2003 | 52,06 | 52,18 | 49,52 | 50,46 | -1,68% | 5,10% | 179.002 |
| 28/10/2003 | 48,77 | 51,54 | 48,66 | 51,32 | +5,79% | 5,91% | 173.498 |
| 27/10/2003 | 47,69 | 49,48 | 47,57 | 48,51 | +4,26% | 4,00% | 343.630 |
| 24/10/2003 | 46,56 | 47,05 | 45,66 | 46,53 | -1,35% | 2,97% | 114.855 |
| 23/10/2003 | 45,36 | 47,27 | 44,02 | 47,16 | +2,86% | 7,18% | 204.329 |
| 22/10/2003 | 46,79 | 47,46 | 45,03 | 45,85 | -1,13% | 5,20% | 181.914 |
| 21/10/2003 | 43,42 | 46,64 | 43,42 | 46,38 | +6,72% | 7,41% | 290.624 |
| 20/10/2003 | 43,27 | 44,54 | 42,78 | 43,46 | +0,00% | 4,07% | 454.157 |
| 17/10/2003 | 44,47 | 44,73 | 42,48 | 43,46 | -1,86% | 5,05% | 201.925 |
| 16/10/2003 | 44,88 | 45,25 | 44,13 | 44,28 | -1,58% | 2,50% | 199.306 |
| 15/10/2003 | 46,30 | 47,39 | 44,43 | 44,99 | -2,04% | 6,39% | 250.522 |
| 14/10/2003 | 46,30 | 47,65 | 45,33 | 45,93 | +0,49% | 5,01% | 320.627 |
| 13/10/2003 | 44,43 | 45,96 | 44,43 | 45,70 | +1,83% | 3,45% | 309.005 |
| 10/10/2003 | 45,59 | 45,59 | 43,98 | 44,88 | -2,52% | 3,53% | 152.739 |
| 09/10/2003 | 46,71 | 46,90 | 45,66 | 46,04 | -1,13% | 2,64% | 142.373 |
| 08/10/2003 | 47,31 | 47,80 | 46,38 | 46,56 | -1,97% | 3,01% | 100.909 |
| 07/10/2003 | 46,60 | 47,99 | 46,49 | 47,50 | -0,63% | 3,21% | 175.181 |
| 06/10/2003 | 47,46 | 48,17 | 46,71 | 47,80 | -0,23% | 3,08% | 166.258 |
| 03/10/2003 | 48,10 | 48,85 | 47,50 | 47,91 | +0,79% | 2,80% | 143.228 |
| 02/10/2003 | 47,91 | 49,41 | 47,42 | 47,54 | -0,70% | 4,14% | 186.937 |
| 01/10/2003 | 48,13 | 49,52 | 46,41 | 47,87 | -0,85% | 6,45% | 249.934 |
| 30/09/2003 | 46,94 | 48,66 | 46,26 | 48,28 | +2,87% | 5,10% | 375.636 |
| 29/09/2003 | 45,14 | 47,42 | 43,68 | 46,94 | +3,98% | 8,29% | 349.027 |
| 26/09/2003 | 46,15 | 46,64 | 45,10 | 45,14 | -2,58% | 3,33% | 121.828 |
| 25/09/2003 | 46,79 | 48,88 | 45,51 | 46,34 | -0,64% | 7,20% | 227.118 |
| 24/09/2003 | 48,77 | 49,18 | 45,66 | 46,64 | -4,15% | 7,21% | 455.840 |
| 23/09/2003 | 49,37 | 49,74 | 48,47 | 48,66 | -1,52% | 2,58% | 232.382 |
| 22/09/2003 | 51,80 | 51,80 | 47,91 | 49,41 | -4,56% | 7,51% | 806.336 |